FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

788328006: Polatuzumab vedotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3779936019 Polatuzumab vedotin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779937011 Polatuzumab vedotin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Polatuzumab vedotin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Microtubule inhibitor (disposition) true Inferred relationship Some
Polatuzumab vedotin Is a Microtubule inhibitor true Inferred relationship Some
Polatuzumab vedotin Is a Monoclonal antibody true Inferred relationship Some
Polatuzumab vedotin Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Polatuzumab vedotin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Polatuzumab vedotin Inferred relationship Some 1
Product containing only polatuzumab vedotin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Polatuzumab vedotin Inferred relationship Some 1
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Polatuzumab vedotin Inferred relationship Some 1
Polatuzumab vedotin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Polatuzumab vedotin Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start